ClinicalTrials.Veeva

Menu

Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status

Completed

Conditions

Well Child Care Visit
Immunization Status

Treatments

Other: Autodialer
Other: Letters

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT01057888
RSRB00026761

Details and patient eligibility

About

The investigators will design and implement a randomized clinical trial to test, on a community-wide level, the effectiveness of managed care based tracking/reminder/recall on improving vaccination coverage among adolescents.

The investigators propose a randomized controlled trial to evaluate the effectiveness of reminder/recall for adolescents: 10,599 adolescents within the managed care organization (MCO) will be randomized into one of three arms: 1) mailed reminders, 2) autodialer telephone messages or 3) standard of care of their practice (no messages from the intervention).

Hypothesis 1: Reminder/recall will increase the receipt of immunizations and preventive services

Hypothesis 2: Telephone (autodialer) reminders will be more effective than mailed reminders

Hypothesis 3: The impact of reminders will be greatest for the most high-risk subgroups which have low baseline immunization rates.

Hypothesis 4: Mailed reminders will be more costly (and less effective) than telephone reminders.

Enrollment

10,599 patients

Sex

All

Ages

11 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Member of the Monroe Plan for Medical Care (managed care organization)
  • Patient of a participating practice
  • Ages 10.75 to <18 years of age

Exclusion criteria

  • Member of the Monroe Plan for Medical care for less than 6 months
  • ICD-9 diagnosis of 999.4 for anaphylactic reaction to a vaccine or its components.
  • Encephalopathy within 7 days of a previous dose of a pertussis containing vaccine not attributable to another identifiable cause
  • Guillain-Barre- ICD-9 code is 357.0

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

10,599 participants in 3 patient groups

Autodialer
Experimental group
Description:
Autodialer reminder/recall
Treatment:
Other: Autodialer
Letters
Experimental group
Description:
Mailed reminder letters
Treatment:
Other: Letters
Controls
No Intervention group
Description:
Controls

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems